Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$214M |
| 2 |
Verizon
VZ
|
+$148M |
| 3 |
Otis Worldwide
OTIS
|
+$142M |
| 4 |
Baidu
BIDU
|
+$124M |
| 5 |
Alibaba
BABA
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$324M |
| 2 |
Amazon
AMZN
|
+$313M |
| 3 |
Bank of America
BAC
|
+$264M |
| 4 |
AGN
Allergan plc
AGN
|
+$259M |
| 5 |
Wells Fargo
WFC
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.39% |
| 2 | Financials | 16.29% |
| 3 | Industrials | 12.76% |
| 4 | Healthcare | 11.61% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Teva Pharmaceuticals
TEVA
$40.8B
| $31.1M | 0.01% |
2,524,777
-348,513
| -12% | -$3.94M |
|
1577
Champion Homes
SKY
$4.37B
| $31.1M | 0.01% |
1,278,797
+109,984
| +9% | +$2.29M |
|
1578
HEICO Corp Class A
HEI.A
$36B
| $31.1M | 0.01% |
383,072
+7,582
| +2% | +$588K |
|
1579
Pilgrim's Pride
PPC
$6.51B
| $31.1M | 0.01% |
1,841,572
+262,262
| +17% | +$5.11M |
|
1580
Cleveland-Cliffs
CLF
$6.57B
| $31.1M | 0.01% |
5,630,612
-3,632,416
| -39% | -$17.7M |
|
1581
Hyster-Yale Materials Handling
HY
$599M
| $31.1M | 0.01% |
803,341
+8,824
| +1% | +$329K |
|
1582
Teladoc Health
TDOC
$1.22B
| $31M | 0.01% |
162,717
-23,889
| -13% | -$4.19M |
|
1583
Match Group
MTCH
$9.19B
| $30.9M | 0.01% |
288,346
+4,820
| +2% | +$403K |
|
1584
Omega Flex
OFLX
$297M
| $30.8M | 0.01% |
291,089
-82
| -0% | -$7.8K |
|
|
CSW
1585
CSW Industrials
CSW
$5.2B
| $30.8M | 0.01% |
445,396
-17,023
| -4% | -$1.15M |
|
1586
NiSource
NI
$21.3B
| $30.7M | 0.01% |
1,350,772
+8,277
| +0.6% | +$200K |
|
1587
Costamare
CMRE
$1.88B
| $30.7M | 0.01% |
5,520,921
+221,993
| +4% | +$1.08M |
|
1588
Manitowoc
MTW
$497M
| $30.7M | 0.01% |
2,821,319
+113,706
| +4% | +$1.08M |
|
|
TARO
1589
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $30.6M | 0.01% |
460,887
+10,884
| +2% | +$730K |
|
1590
Resources Connection
RGP
$151M
| $30.6M | 0.01% |
2,556,203
+18,583
| +0.7% | +$201K |
|
|
CIR
1591
DELISTED
CIRCOR International, Inc
CIR
| $30.6M | 0.01% |
1,200,218
-216,221
| -15% | -$3.37M |
|
1592
Ultragenyx Pharmaceutical
RARE
$2.45B
| $30.5M | 0.01% |
389,793
-18,725
| -5% | -$1.24M |
|
|
HSII
1593
DELISTED
Heidrick & Struggles
HSII
| $30.5M | 0.01% |
1,409,726
+22,683
| +2% | +$499K |
|
1594
Universal Insurance Holdings
UVE
$1.22B
| $30.5M | 0.01% |
1,716,163
+16,530
| +1% | +$292K |
|
|
CHNG
1595
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $30.5M | 0.01% |
2,719,539
-73,856
| -3% | -$830K |
|
1596
Waterstone Financial
WSBF
$370M
| $30.3M | 0.01% |
2,043,842
+15,558
| +0.8% | +$220K |
|
1597
Clearway Energy Class C
CWEN
$4.94B
| $30.3M | 0.01% |
1,312,270
-11,646
| -0.9% | -$246K |
|
|
AIMC
1598
DELISTED
Altra Industrial Motion Corp
AIMC
| $30.2M | 0.01% |
948,888
+68,480
| +8% | +$1.81M |
|
1599
CenterPoint Energy
CNP
$27.7B
| $30.2M | 0.01% |
1,618,985
-773
| -0% | -$13.3K |
|
|
CDK
1600
DELISTED
CDK Global, Inc.
CDK
| $30.2M | 0.01% |
728,603
-32,305
| -4% | -$1.24M |
|
Similar funds
Dimensional Fund Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Dimensional Fund Advisors held 3,428 positions worth $228B, up 19% from $192B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q2 2020: portfolio turnover was 4.2%. Dimensional Fund Advisors opened 54 new positions and exited 89, leaving the 3,428-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2020 buy was Otis Worldwide: 2,746,401 shares worth $156M.
- Dimensional Fund Advisors added most to AbbVie in Q2 2020, an estimated $214M increase.
- Dimensional Fund Advisors's biggest Q2 2020 reduction was Apple, cutting an estimated $324M.
- Dimensional Fund Advisors fully exited Allergan plc in Q2 2020, selling an estimated $259M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $228B portfolio in Q2 2020.
- Dimensional Fund Advisors opened 54 new positions and closed 89 in Q2 2020.
- Dimensional Fund Advisors's portfolio value rose 19% quarter-over-quarter to $228B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.